Rheumatic Arthritis Clinical Trial
Official title:
Phase II Study of Physiotherapy in Rheumatoid Arthritis: Randomized Single Blind Wait-list Controlled Trial
Despite leading cause of morbidity, treatment strategies for Rheumatic diseases are geared
almost exclusively toward medical-pharmacological area away from offering the patient the
possibility of an interdisciplinary approach to their disease.
Present study test whether treatment of physiotherapy reduces stiffness and pain inherent in
rheumatic disease and improve their quality of life related to health.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT03685110 -
CoreHip - Post Market Clinical Follow-Up Study
|
||
| Recruiting |
NCT04485325 -
Capability of Tofacitinib or Etanercept to Accelerate Tapering of NSAID and Treat-to-target Guided De-escalation of Corticosteroids in RA Patients
|
Phase 4 | |
| Completed |
NCT01525147 -
Phase I Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of YHB1411-2 in Healthy Male Volunteers
|
Phase 1 | |
| Recruiting |
NCT05007340 -
ILD-SARDs Registry and Biorepository
|
||
| Completed |
NCT05291130 -
AESCULAP® Plasmafit® Cementless Acetabular System With Vitelene® Vitamin E Stabilized Highly Crosslinked Polyethylene
|
||
| Active, not recruiting |
NCT04255966 -
Plasmafit® Revision Structan® Hip Endoprosthesis Cup
|